According to the FDA, there have been more than 290 reports of subacute stent thrombosis (> 24 hours and < 30 days after stent implantation) that occurred in patients treated with the recently ...

New data from a real-world registry of patients undergoing PCI at a large European center suggest that Synergy (Boston Scientific), a thin-strut everolimus-eluting stent with a biodegradable polymer, ...

A report from the nationwide complete Swedish Coronary Angiography and Angioplasty Registry (SCAAR) Results from the SCAAR study, presented at the ESC Congress 2011 today, showed that Percutaneous ...

The initial trials of drug-eluting stents (DESs) demonstrated marked reductions in restenosis and the need for repeat revascularization procedures, and resulted in the near instantaneous adoption of ...

Introduction Is Long-term Single Antiplatelet Clopidogrel Therapy Safe After Drug-Eluting Stent Implantation in Patients on Anticoagulants? MATRIX Registry: Duration of Dual Antiplatelet Therapy After ...

Stents are permanent mesh tubes that help direct blood flow to the heart or other organs. Usually, stents are not replaced but may be reinforced. However, some people may experience issues such as ...

Please provide your email address to receive an email when new articles are posted on . A stent coated with site-specific antithrombotic therapy safely managed thrombotic and bleeding risk after PCI.

The Svelte stent, designed to facilitate direct stenting and transradial access in percutaneous coronary intervention (PCI), did not differ significantly from metallic everolimus-eluting stents with ...

A study, published in The New England Journal of Medicine, compared drug-eluting bioresorbable vascular scaffolds with drug-eluting metallic stents in percutaneous coronary interventions. Abbott ...

PARIS, France—Drug-eluting stents appear to be better than drug-coated balloons (DCBs) at treating in-stent restenosis, at least when it comes to preventing TLR, but the difference isn’t particularly ...